Cenes Limited
Records under this name other than patents Cenes Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,777,007 | Short-acting benzodiazepine salts and their polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,914,738 | Short-acting benzodiazepine salts and their polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,472,365 | Short-acting benzodiazepine salts and their polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,961,250 | Short-acting benzodiazepine salts and their polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,642,588 | Short-acting benzodiazepine salts and their polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,365,684 | Short-acting benzodiazepine salts and their polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,193,730 | Short-acting benzodiazepine salts and their polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,160,880 | Short-Acting Benzodiazepines Formerly held Term ended Term ended May 12, 2020 · High confidence | Term ended | Term ended May 12, 2020 | High confidence |
| US 7,435,730 | Short-acting benzodiazepines Formerly held Term ended Term ended May 12, 2020 · From the USPTO record | Term ended | Term ended May 12, 2020 | From the USPTO record |
| US 7,473,689 | Short-acting benzodiazepines Formerly held Term ended Term ended May 12, 2020 · From the USPTO record | Term ended | Term ended May 12, 2020 | From the USPTO record |